As the largest charity in the world dedicated to defeating ovarian cancer, OCRA is on the cutting edge of scientific innovation. We’re here for patients and families as they face the everyday challenges that accompany a life-altering diagnosis, and we lead the charge in advocating for legislative policies that help the ovarian cancer community. Yet, … Continued
Spread the word. Make a difference. Ready to help this Ovarian Cancer Awareness Month? You can share critical information on risk and symptoms by downloading the graphics below (right-click and save to your computer), firing up your social media accounts, and sharing widely! If you haven’t taken our educational quiz — or you need a … Continued
For Amber Jean Young, the loss of her mother to ovarian cancer on January 1, 2019, caused a grief so acute that it completely altered an essential part of her identity: her art. An interdisciplinary artist who holds a Master of Fine Art from San Francisco Art Institute, Amber had been primarily working with textiles … Continued
Some may think video games are just for play, but these three streamers are committed to using their pastime to make a serious difference for the ovarian cancer community. Our #GameOVAR ambassadors Tamborine Panda, Isabella and Podgie are raising support for lifesaving research through August 14 during OCRA’s first-ever streaming event through Tiltify. Read on to learn … Continued
Planned giving can be an uncomfortable conversation for many; after all, it’s a conversation about what happens when we die. And talking about it within the context of our community – those touched by the deadliest gynecologic cancer – can feel awkward, if not downright off-putting. But planned giving is an important fundraising component of … Continued
A recent study partly funded by OCRA, and published in the Journal of Clinical Oncology, has shown that frequent aspirin use (defined as more than six times per week for more than six months) is associated with a reduction in ovarian cancer risk. Three members of OCRA’s Scientific Advisory Committee – Dr. Andrew Berchuck (also … Continued
Our gratitude goes out to three OCRA Heroes who channeled their creative energy to champion our shared cause via inventive fundraising initiatives. Entrepreneur Daisy Garcia in California, personal care brand founder Julie Hogan in Florida, and artist Andrew Galdi in Pennsylvania have all been motivated to use their talents to contribute to the ovarian cancer … Continued
A recent study published in Nature Cancer talks about harnessing the power of machine learning to help predict prognosis and response to treatment for those with high-grade serous ovarian cancer (HGSOC). The study is co-authored by OCRA grantees Sohrab Shah, PhD, of Memorial Sloan Kettering Cancer Center – a two-time OCRA grant recipient, most recently … Continued
The following is a statement from The White House, published on July 13, 2022. Today, President Joe Biden announced his intent to appoint Dr. Mitchel Berger, Dr. Carol Brown, and Dr. Elizabeth Jaffee to the President’s Cancer Panel. The three are distinguished members of the scientific, research, and public health communities appointed by the President … Continued
We hope everyone is enjoying some sunshine while keeping cool and hydrated. OCRA is keeping busy – planning our Uniting for Hope Ovarian Cancer National Conference; offering support to patients and their loved ones; funding grantees and their quest for better treatments and a cure. Read on to see the latest. Research Advocacy Patient Support … Continued
In a promising development for our community, the House Appropriations Committee recently approved the fiscal year 2023 Labor, Health and Human Services, Education, and Related Agencies bill, which contains significant funding increases for key ovarian cancer programs. We urge the Senate to support these same FY23 program funding levels, which can make a crucial difference … Continued
Targeting a specific oncogene associated with the most common type of ovarian cancer may help increase a patient’s immune response to tumors, according to recent findings from researchers at The Wistar Institute and their colleagues at University of Pennsylvania and The University of Colorado Anschutz Medical Campus. An oncogene is a mutated version of a … Continued
Get email updates about research news, action alerts, and ways to join the fight.
